Abraxis unveils $70M manufacturing plant in Phoenix

Abraxis Biosciences opened a $70 million facility in Phoenix that will produce Abraxane, a chemotherapy drug for metastatic breast cancer, and other treatments in its pipeline. The manufacturing plant is expected to generate as many as 200 high-tech jobs.

View Full Article in:

Arizona Republic (Phoenix) (tiered subscription model), The · American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ